wheeled carts that can be moved and set up in different operating rooms. (Medtronic)
Hugo is going on a whirlwind international tour. Medtronic’s modular surgical robot has received a series of new regulatory approvals the company says will greatly expand access to the system across Europe, Canada and Japan.
That includes green lights for minimally invasive procedures in general surgery, urology and gynecology the medtech giant estimates currently account for more than 80% of robotic-assisted surgeries worldwide.
The system collected a new CE mark in Europe for general surgery—which spans several different medical specialties, including the fast-growing market for hernia repairs. That builds on the regulatory approvals it obtained there in October 2021 covering urologic and gynecological procedures.
Meanwhile, in North America, Health Canada granted Hugo a general laparoscopic surgery indication, and Japan’s Ministry of Health, Labour and Welfare gave its blessing for laparoscopic procedures in urology and gynecology.
“These regulatory approvals are a major step in expanding the benefits of minimally invasive surgery to patients around the world. We truly believe that AI-assisted robotic surgery will transform the operating room,” Carla Peron, M.D., Medtronic’s chief medical officer for surgical robotics, said in a release.
RELATED: FDA clears Impella low-profile sheath from Abiomed
The Hugo robot—which is also being used in general surgery procedures in Latin and South America as well as in the Asia-Pacific region—includes up to four arms mounted on separate wheeled carts that can be moved and set up in different operating rooms.
It has been employed for procedures such as gastric bypass, gallbladder removal and lower anterior resections of the rectum to treat cancer.
Equipped with wristed instruments and 3D visualization tools, the system can also automatically record an entire procedure, allowing the data to be used in future training sessions through Medtronic’s Touch Surgery software.
Hugo is currently being studied in the U.S. and is not yet available for sale. The system made its international surgical debut in Santiago, Chile, where it helped perform a minimally invasive prostatectomy in June 2021.
Are you Hiring?
